TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

AI Designing Drugs: Navigating the Hype

Robotic arm holding out a generic pill bottle.
Insight by and

Yaron Werber, Biotechnology Analyst and Steven Mah, Life Science and Diagnostic Tools Analyst interview biotherapeutic executives on how artificial intelligence is revolutionizing drug discovery for autoimmune disorders and oncology.

They discuss using machine learning and AI to expedite drug discovery and development, how they aid in designing drugs that have higher success rates,  and challenges to building a drug company using machine learning.

Interviewees are:

Sanjiv Patel, President and CEO, Relay Therapeutics

Sean McClain, Founder and CEO, Absci

Jason Silvers, Chief Financial Officer, Generate Biomedicines  

Get the Full Report

If you’re already a member of our Research portal, log in.

Log In

If not, reach out to us directly for more information.